Diets
intensive lifestyle program slows early-stage prostate cancer
In plain terms: Can this lifestyle program slow early prostate cancer so men can avoid treatment?
Part of: 🥗 intensive lifestyle program
Weak and unconfirmed: Ornish's own small trial showed lower PSA and less treatment, but the one large independent diet RCT found no effect on progression, and no trial shows the vegan diet component alone matters.
📅 Last reviewed: 2026-07-14 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: Human trials (RCT / n-of-1)
How the studies fall
What the evidence shows
Weak and unconfirmed. The programme's own small trial reported lower PSA and less subsequent treatment, but the one large independent randomised test, MEAL in 478 men on active surveillance, found a vegetable-enriched diet did not reduce progression. The remaining support is a telomere surrogate and small uncontrolled studies.
The evidence (10)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Dewell A, Weidner G, Sumner MD, Chi CS, Ornish D 2008 · J Am Diet Assoc | RCT | supports | low | Same cohort mechanism paper: confirms large shifts in protective/pathogenic nutrients — shows adherence, not clinical progression. |
| Parsons JK, Zahrieh D, Mohler JL, Paskett E, Hansel DE, Kibel AS, Liu H, Seisler DK, Natarajan L, White M, Hahn O, Taylor J, Hartman SJ, Stroup SP, Van Veldhuizen P, Hall L, Small EJ, Morris MJ, Pierce JP, Marshall J 2020 · JAMA | RCT | contradicts | high | MEAL RCT n=478 active surveillance: vegetable-enriched diet did NOT reduce prostate cancer progression vs control (HR ~0.96). |
| Ballon-Landa E, Parsons JK 2018 · Curr Opin Urol | observational | mixed | moderate | Independent review concludes nutrition/lifestyle evidence for altering prostate-cancer course is suggestive but inconclusive, with few adequately powered trials. |
| Zuniga KB, Chan JM, Ryan CJ, Kenfield SA 2020 · Urol Oncol | observational | mixed | moderate | Review of diet/lifestyle RCTs+cohorts: evidence for slowing progression remains limited and inconsistent; recommendations largely observational/expert-opinion. |
| Ornish D, Lin J, Chan JM, Epel E, Kemp C, Weidner G, Marlin R, Frenda SJ, Magbanua MJM, Daubenmier J, Estay I, Hills NK, Chainani-Wu N, Carroll PR, Blackburn EH 2013 · Lancet Oncol | RCT | supports | moderate | 5-year follow-up of the lifestyle-intervention pilot found increased telomerase/telomere length, a surrogate marker, same PCLT cohort and Ornish group. |
| Aja PM, Agu PC, Musyoka AM, Ngwueche W, Odo JU, Alum EU, Fasogbon IV, Herbert M, Daniel Eze E 2025 · American journal of men's health | observational | supports | low | Narrative review (not a primary trial, no n reported) of nutrition/exercise/lifestyle in prostate disease broadly; states plant-based diets and specific bioactive compounds (lycopene, omega-3s, polyphenols) are 'linked to reduced disease pr |
| Saxe GA, Hébert JR, Carmody JF, Kabat-Zinn J, Rosenzweig PH, Jarzobski D, Reed GW, Blute RD 2001 · J Urol | n-of-1 | mixed | low | Small independent diet+stress-reduction study: slowed rate of PSA rise after biochemical recurrence; tiny, uncontrolled-grade. |
| Campetella M, Bizzarri FP, Russo P, Bientinesi R, Filomena GB, Sighinolfi MC, Rocco B, Sacco E 2026 · Journal of clinical medicine | observational | tested-null | moderate | Systematic review (PRISMA/PROSPERO) of >30 studies of lifestyle interventions (diet, exercise, weight, supplements) in men on active surveillance for prostate cancer; not an Ornish-specific trial. Exercise improved fitness/QoL but dietary c |
| Allen R, Liu V, Chan JM, Graff RE, Stampfer MJ, Aronson WJ, Kenfield SA 2026 · The Journal of urology | meta-analysis | mixed | moderate | Systematic review of 21 postdiagnosis diet/lifestyle cohort and trial studies (2005-2025) in PCa survivors; plant-based/healthful dietary patterns and lower insulinemic-potential diets were associated with lower risk of PCa progression and |
| Ornish D, Weidner G, Fair WR, Marlin R, Pettengill EB, Raisin CJ, Dunn-Emke S, Crutchfield L, Jacobs FN, Barnard RJ, Aronson WJ, McCormac P, McKnight DJ, Fein JD, Dnistrian AM, Weinstein J, Ngo TH, Mendell NR, Carroll PR 2005 · J Urol | RCT | supports | low | 93 men, watchful waiting, 1yr: PSA -4% intervention vs +6% control; 0/44 vs 6/49 underwent conventional treatment; serum inhibited LNCaP growth 8x more. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.